$MSIF Balance Sheet | Understand Stock

$MSIF

$11.44 -$0.10 (0.87%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023
ASSETS
Investments at fair value
Control investments:
Affiliate investments:
Non‑Control/Non‑Affiliate investments:
Total investments at fair value
Cash and cash equivalents
Interest and dividend receivable
Receivable for securities sold
Prepaids and other assets
Deferred tax asset, net
Deferred financing costs (net of accumulated amortization of $7,692 and $7,259, respectively)
Total assets
LIABILITIES
Debt
Accounts payable and other liabilities
Payable for securities purchased
Interest payable
Dividend payable
Management and incentive fees payable
Base management and incentive fees payable
Capital gains incentive fee accrual
Deferred tax liability, net
Total liabilities
NET ASSETS
Common stock, $0.001 par value per share (450,000,000 shares authorized; 45,345,229 and 46,588,608 shares issued and outstanding, respectively)
Additional paid-in capital
Total overdistributed earnings
Total net assets
Total liabilities and net assets
NET ASSET VALUE PER SHARE (in dollars per share)

Comments